Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei Inhibitors
AU - Florence, Gordon J.
AU - Fraser, Andrew L.
AU - Gould, Eoin R.
AU - King, Elizabeth F.
AU - Menzies, Stefanie K.
AU - Morris, Joanne C.
AU - Thomson, Marie I.
AU - Tulloch, Lindsay B.
AU - Zacharova, Marija K.
AU - Smith, Terry K.
N1 - Publisher Copyright: © 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2016/7/19
Y1 - 2016/7/19
N2 - Neglected tropical diseases caused by parasitic infections are an ongoing and increasing concern. They are a burden to human and animal health, having the most devastating effect on the world′s poorest countries. Building upon our previously reported triazole analogues, in this study we describe the synthesis and biological testing of other novel heterocyclic acetogenin-inspired derivatives, namely 3,5-isoxazoles, furoxans, and furazans. Several of these compounds maintain low-micromolar levels of inhibition against Trypanosoma brucei, whilst having no observable inhibitory effect on mammalian cells, leading to the possibility of novel lead compounds for selective treatment.
AB - Neglected tropical diseases caused by parasitic infections are an ongoing and increasing concern. They are a burden to human and animal health, having the most devastating effect on the world′s poorest countries. Building upon our previously reported triazole analogues, in this study we describe the synthesis and biological testing of other novel heterocyclic acetogenin-inspired derivatives, namely 3,5-isoxazoles, furoxans, and furazans. Several of these compounds maintain low-micromolar levels of inhibition against Trypanosoma brucei, whilst having no observable inhibitory effect on mammalian cells, leading to the possibility of novel lead compounds for selective treatment.
KW - drug discovery
KW - natural product analogues
KW - trypanosomatids
KW - [3+2] cycloaddition
U2 - 10.1002/cmdc.201600210
DO - 10.1002/cmdc.201600210
M3 - Journal article
C2 - 27283448
AN - SCOPUS:84978763282
VL - 11
SP - 1503
EP - 1506
JO - ChemMedChem
JF - ChemMedChem
SN - 1860-7179
IS - 14
ER -